Syringes containing Engerix B Vaccine

Made:
1993 in England

Box containing ten disposable syringes, each prefilled with 1ml of Engerix B Vaccine, bioengineered and grown in yeast, for intramuscular injection to protect against Hepatitis B, by SmithKline Beecham Pharmaceuticals, Welwyn Garden City, England, 1993Engerix B Vaccine, bioengineered and grown in yeast, for intramuscular injection to protect against Hepatitis B, by SmithKline Beecham Pharmaceuticals, Welwyn Garden City, England, 1993

Details

Category:
Public Health & Hygiene
Object Number:
1994-139
type:
vaccine
credit:
SmithKline Beecham Pharmaceuticals

Parts

Ten disposable vaccination syringes to protect against hepatitis B, Belgium, 1993

Ten disposable vaccination syringes to protect against hepatitis B, Belgium, 1993

Box containing ten disposable syringes, each prefilled with 1ml of Engerix B Vaccine, bioengineered and grown in yeast, for intramuscular injection to protect against Hepatitis B, by SmithKline Beecham Pharmaceuticals, Welwyn Garden City, England, 1993


Hepatitis B is a disease that causes inflammation of the liver. Long term effects include liver diseases and liver cancer. The vaccine was introduced in the 1980s. It is thought that immunity from vaccination is for life, although this has not been confirmed. ‘Engerix B’ was the first commercially made and sold bio-engineered vaccine. Made by SmithKline Beecham Pharmaceuticals, the vaccine was grown in yeast.